Anzeige
Mehr »
Login
Samstag, 11.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
100 % Anstieg in zwei Tagen: Das technische Signal, das Wall Streets Bären in Panik versetzt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
97 Leser
Artikel bewerten:
(0)

National Retail Solutions: NRSInsights' November 2024 Retail Same-Store Sales Report

Finanznachrichten News

November same-store sales increased 6.6% year-over-year

NEWARK, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) -- NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative same-store sales results for November 2024.

As of November 30, 2024, the NRS retail network comprised approximately 33,600 active terminals nationwide, scanning purchases at approximately 29,200 independent retailers including convenience stores, bodegas, liquor stores, grocers, tobacco, and sundries sellers nationwide, predominantly serving urban consumers.

November Retail Same-Store Sales Highlights

(Same-store sales, unit sales, transactions, and average price data throughout this release refer to November 2024 and are compared to November 2023 unless otherwise noted. All comparisons are provided on a "per calendar day" basis to remove from consideration variability in the number of days per month.)

  • SALES
    • Same-store sales increased 6.6% year-over-year. In the previous month (October 2024), same-store sales had increased 3.7% year-over-year.
    • Same-store sales increased 1.5% compared to the previous month (October 2024). Same-store sales in October 2024 had decreased (0.5)% compared to the previous month (September 2024).
    • For the three months ended November 30, 2024, same-store sales increased 3.5% compared to the corresponding three months a year ago.
  • UNITS SOLD
    • The number of units sold increased 4.5% year-over-year. In the previous month (October 2024), the number of units sold had increased 2.8% year-over-year.
    • Units sold decreased (0.4)% compared to the previous month (October 2024). Units sold in October 2024 had decreased (0.5)% compared to the previous month (September 2024).
  • TRANSACTIONS PER STORE
    • The average number of transactions per store increased 3.2% year-over-year. In the previous month (October 2024), transactions had increased 1.6% year-over-year.
    • Transactions decreased (2.5)% compared to the previous month (October 2024). Transactions in October 2024 had decreased (0.7)% compared to the previous month (September 2024).
  • AVERAGE PRICES
    • A dollar-weighted average of prices for the top 500 items purchased increased 3.9% year-over-year, an increase from the 1.9% year-over-year increase recorded in October 2024.

Retail Trade Comparative Data

The table below provides historical comparative data with the U.S. Commerce Department's Advance Monthly Retail Trade same-store sales data excluding food service:

Over the past twelve months, the NRS network's three-month moving average same-store sales have outpaced the US Commerce Department's Advance Monthly Retail Trade data, excluding food services, by 1.3% percentage points, on average.

The NRSInsights data in the chart above have not been adjusted to reflect inflation, demographic distributions, seasonal buying patterns, item substitution, days per month, or other factors that may facilitate comparisons to other periods, to other same-store retail sales data, or to the U.S. Commerce Department's retail data.

Commentary from Suzy Silliman (SVP, Data Strategy and Sales at NRS)

"November was a strong month for most product super categories sold within the NRS Network.

"As in October, beverages were a standout. Both the alcoholic (BEVAL) and the packaged non-alcoholic segments experienced growth across most categories. Within BEVAL, the only categories not showing year-over-year growth in November were Cognac, Brandy, and Sparkling Wine. Within the packaged non-alcoholic beverage segment, all categories grew except Sports Drinks, Fruit Juice, Ready-to-Drink Coffee, and Packaged Smoothies. Notably, Energy Drinks enjoyed a second consecutive month of year-over-year dollar sales growth after months of decline.

"Outside of beverage categories, Chocolate, which has been on a troubling decline, did show YOY growth for both dollars and quantity while Confections were down again from the year ago level. As winter storms swept across many regions, Ice Melt products flew off the shelves at NRS retail stores."

NRSInsights Reports

The NRSInsights monthly Same-Store Retail Sales Reports are intended to provide timely topline data reflective of sales at NRS' network of independent, predominantly urban, retail stores.

Same-store data comparisons of November 2024 with November 2023 are derived from approximately 187 million transactions processed through the approximately 20,100 stores on the NRS network that scanned transactions in both months. Same-store data comparisons of November 2024 with October 2024 are derived from approximately 249 million transactions processed through approximately 28,100 stores.

Same-store data comparisons for the three months ended November 30, 2024 with the year-ago three months are derived from approximately 559 million scanned transactions processed through those stores that were in the NRS network in both quarters.

NRS POS Platform

The NRS platform predominantly serves small-format, independent, retail stores nationwide including convenience stores, bodegas, liquor stores, grocers, tobacco, and sundries sellers. These independent retailers operate in all 50 states as well as the District of Columbia, and in 201 of the 210 designated market areas (DMAs) in the United States. During November 2024, NRS' POS terminals processed $1.8 billion in sales (+23% year-over-year) across 124 million transactions (+19% year-over-year). During the twelve months ended November 30, 2024, NRS store terminals processed $20.6 billion in sales through approximately 1.5 billion transactions.

About National Retail Solutions (NRS):

National Retail Solutions operates the largest point-of-sale (POS) terminal-based platform and digital payment processing service for independent retailers nationwide. Retailers utilize NRS offerings to process transactions and effectively manage their businesses. Consumer packaged goods (CPG) suppliers, brokers, analytics firms, and advertisers access the terminal's digital display network to reach these retailers' predominantly urban, multi-cultural shopper base, and to harness transaction data-based learnings to identify growth opportunities and measure execution and returns on marketing investment. NRS is a subsidiary of IDT Corporation (NYSE: IDT).

All statements above that are not purely about historical facts, including, but not limited to, those in which we use the words "believe," "anticipate," "expect," "plan," "intend," "estimate," "target" and similar expressions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. While these forward-looking statements represent our current judgment of what may happen in the future, actual results may differ materially from the results expressed or implied by these statements due to numerous important factors. Our filings with the SEC provide detailed information on such statements and risks, and should be consulted along with this release. To the extent permitted under applicable law, IDT assumes no obligation to update any forward-looking statements.

NRSInsights Contact:
Suzy Silliman
SVP, Data Strategy and Sales at NRS
National Retail Solutions
suzy.silliman@nrsplus.com

IDT Corporation Contact:
Bill Ulrey
william.ulrey@idt.net

# # #


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.